Načítá se...
Enzalutamide in chemo-naïve castration-resistant prostate cancer: effective for most but not for all
Continued research in the treatment of castration-resistant prostate cancer (CRPC) has allowed for a clearer understanding of this disease entity and further treatment advances. In a study recently published by Beer et al.1 in the New England Journal of Medicine, another advance to treatment was dem...
Uloženo v:
| Vydáno v: | Asian J Androl |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Medknow Publications & Media Pvt Ltd
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4236319/ https://ncbi.nlm.nih.gov/pubmed/25155108 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/1008-682X.137680 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|